US Stock MarketDetailed Quotes

GTHX G1 Therapeutics

Watchlist
  • 4.220
  • -0.090-2.09%
Trading May 23 15:53 ET
220.63MMarket Cap-7033P/E (TTM)

G1 Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
69.37%-8.9M
70.19%-38.34M
58.24%-12.79M
50.22%-10.58M
136.53%14.09M
23.91%-29.05M
2.64%-128.62M
11.62%-30.63M
37.66%-21.25M
-5.67%-38.56M
Net income from continuing operations
62.97%-10.22M
67.49%-47.97M
67.67%-10.88M
27.97%-18.2M
122.08%8.71M
43.90%-27.6M
0.53%-147.56M
15.92%-33.65M
40.49%-25.27M
-0.06%-39.45M
Operating gains losses
----
----
----
----
----
----
-15.76%497K
-60.50%143K
-37.80%51K
39.80%137K
Depreciation and amortization
-9.09%120K
-3.21%513K
-9.49%124K
-8.63%127K
-6.47%130K
14.78%132K
13.01%530K
20.18%137K
18.80%139K
17.80%139K
Other non cash items
-44.01%799K
-32.47%2.08M
-49.78%335K
-59.86%277K
-92.66%43K
25.18%1.43M
80.93%3.08M
-15.14%667K
230.14%690K
112.32%586K
Change In working capital
76.42%-1.5M
1.96%-5.2M
-156.12%-5.02M
368.53%4.18M
135.21%1.98M
-265.88%-6.34M
39.95%-5.31M
-77.06%-1.96M
-163.50%-1.56M
-72.57%-5.61M
-Change in receivables
120.95%1.03M
70.53%-1.59M
-497.21%-3.42M
1,368.42%3.91M
189.97%2.85M
-155.89%-4.93M
0.83%-5.41M
-27.90%-573K
195.68%266K
-3,788.37%-3.17M
-Change in inventory
-116.67%-106K
129.41%3.74M
147.06%1.05M
3,195.31%2.11M
99.07%-57K
114.49%636K
-266.12%-12.71M
-6.35%-2.23M
137.04%64K
-24,716.00%-6.15M
-Change in prepaid assets
15.24%1.93M
-92.37%548K
-59.90%583K
-2,286.21%-692K
-147.92%-1.02M
-54.03%1.67M
312.54%7.18M
21.17%1.45M
-103.31%-29K
140.75%2.12M
-Change in payables and accrued expense
-11.03%-4.13M
-241.81%-8.01M
-418.69%-3.16M
9.26%-1.69M
-65.21%557K
-157.06%-3.72M
111.50%5.65M
-362.93%-610K
-224.97%-1.86M
22.40%1.6M
-Change in other working capital
-11,100.00%-224K
570.83%113K
-3,200.00%-66K
54,400.00%543K
-5,071.43%-362K
85.71%-2K
-103.02%-24K
-140.00%-2K
-100.29%-1K
-101.32%-7K
Cash from discontinued investing activities
Operating cash flow
69.37%-8.9M
70.19%-38.34M
58.24%-12.79M
50.22%-10.58M
136.53%14.09M
23.91%-29.05M
2.64%-128.62M
11.62%-30.63M
37.66%-21.25M
-5.67%-38.56M
Investing cash flow
Cash flow from continuing investing activities
81.75%5.29M
105.56%2.81M
62.44%-7.65M
124.28%7.2M
168.38%346K
2.91M
-50.53M
-20.36M
-29.66M
-506K
Net PPE purchase and sale
--1K
--0
--0
--0
--0
--0
---506K
--0
--0
----
Net investment purchase and sale
81.72%5.29M
105.62%2.81M
62.44%-7.65M
124.28%7.2M
--346K
--2.91M
---50.02M
---20.36M
---29.66M
--0
Cash from discontinued investing activities
Investing cash flow
81.75%5.29M
105.56%2.81M
62.44%-7.65M
124.28%7.2M
168.38%346K
--2.91M
---50.53M
---20.36M
---29.66M
---506K
Financing cash flow
Cash flow from continuing financing activities
-3,975.70%-8.72M
-151.27%-26.91M
-99.94%34K
-82.68%22K
-26.75M
-1,288.89%-214K
-64.01%52.5M
19.64%52.35M
-93.90%127K
0
Net issuance payments of debt
---8.75M
---26.69M
--1K
---1K
---26.69M
--0
--0
--0
--0
----
Net common stock issuance
----
--0
-99.46%281K
----
----
----
-39.39%52.38M
--52.38M
----
----
Proceeds from stock option exercised by employees
2,500.00%26K
-63.23%57K
230.00%33K
-81.89%23K
--0
-94.44%1K
-97.35%155K
-41.18%10K
-93.90%127K
--0
Net other financing activities
----
-553.49%-281K
----
----
---66K
---215K
96.95%-43K
----
----
----
Cash from discontinued financing activities
Financing cash flow
-3,975.70%-8.72M
-151.27%-26.91M
-99.94%34K
-82.68%22K
---26.75M
-1,288.89%-214K
-64.01%52.5M
19.64%52.35M
-93.90%127K
--0
Net cash flow
Beginning cash position
-65.79%32.47M
-57.16%94.91M
-43.48%52.87M
-61.04%56.23M
-62.62%68.55M
-57.16%94.91M
6.62%221.56M
-55.97%93.55M
-40.96%144.33M
-34.38%183.4M
Current changes in cash
53.22%-12.33M
50.70%-62.44M
-1,604.79%-20.41M
93.40%-3.35M
68.45%-12.32M
30.94%-26.36M
-1,020.79%-126.65M
-85.09%1.36M
-58.71%-50.78M
-11.59%-39.06M
End cash Position
-70.62%20.14M
-65.79%32.47M
-65.79%32.47M
-43.48%52.87M
-61.04%56.23M
-62.62%68.55M
-57.16%94.91M
-57.16%94.91M
-55.97%93.55M
-40.96%144.33M
Free cash flow
69.37%-8.9M
70.31%-38.34M
58.24%-12.79M
50.22%-10.58M
136.06%14.09M
23.91%-29.05M
2.26%-129.13M
11.62%-30.63M
37.66%-21.25M
-7.06%-39.06M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 69.37%-8.9M70.19%-38.34M58.24%-12.79M50.22%-10.58M136.53%14.09M23.91%-29.05M2.64%-128.62M11.62%-30.63M37.66%-21.25M-5.67%-38.56M
Net income from continuing operations 62.97%-10.22M67.49%-47.97M67.67%-10.88M27.97%-18.2M122.08%8.71M43.90%-27.6M0.53%-147.56M15.92%-33.65M40.49%-25.27M-0.06%-39.45M
Operating gains losses -------------------------15.76%497K-60.50%143K-37.80%51K39.80%137K
Depreciation and amortization -9.09%120K-3.21%513K-9.49%124K-8.63%127K-6.47%130K14.78%132K13.01%530K20.18%137K18.80%139K17.80%139K
Other non cash items -44.01%799K-32.47%2.08M-49.78%335K-59.86%277K-92.66%43K25.18%1.43M80.93%3.08M-15.14%667K230.14%690K112.32%586K
Change In working capital 76.42%-1.5M1.96%-5.2M-156.12%-5.02M368.53%4.18M135.21%1.98M-265.88%-6.34M39.95%-5.31M-77.06%-1.96M-163.50%-1.56M-72.57%-5.61M
-Change in receivables 120.95%1.03M70.53%-1.59M-497.21%-3.42M1,368.42%3.91M189.97%2.85M-155.89%-4.93M0.83%-5.41M-27.90%-573K195.68%266K-3,788.37%-3.17M
-Change in inventory -116.67%-106K129.41%3.74M147.06%1.05M3,195.31%2.11M99.07%-57K114.49%636K-266.12%-12.71M-6.35%-2.23M137.04%64K-24,716.00%-6.15M
-Change in prepaid assets 15.24%1.93M-92.37%548K-59.90%583K-2,286.21%-692K-147.92%-1.02M-54.03%1.67M312.54%7.18M21.17%1.45M-103.31%-29K140.75%2.12M
-Change in payables and accrued expense -11.03%-4.13M-241.81%-8.01M-418.69%-3.16M9.26%-1.69M-65.21%557K-157.06%-3.72M111.50%5.65M-362.93%-610K-224.97%-1.86M22.40%1.6M
-Change in other working capital -11,100.00%-224K570.83%113K-3,200.00%-66K54,400.00%543K-5,071.43%-362K85.71%-2K-103.02%-24K-140.00%-2K-100.29%-1K-101.32%-7K
Cash from discontinued investing activities
Operating cash flow 69.37%-8.9M70.19%-38.34M58.24%-12.79M50.22%-10.58M136.53%14.09M23.91%-29.05M2.64%-128.62M11.62%-30.63M37.66%-21.25M-5.67%-38.56M
Investing cash flow
Cash flow from continuing investing activities 81.75%5.29M105.56%2.81M62.44%-7.65M124.28%7.2M168.38%346K2.91M-50.53M-20.36M-29.66M-506K
Net PPE purchase and sale --1K--0--0--0--0--0---506K--0--0----
Net investment purchase and sale 81.72%5.29M105.62%2.81M62.44%-7.65M124.28%7.2M--346K--2.91M---50.02M---20.36M---29.66M--0
Cash from discontinued investing activities
Investing cash flow 81.75%5.29M105.56%2.81M62.44%-7.65M124.28%7.2M168.38%346K--2.91M---50.53M---20.36M---29.66M---506K
Financing cash flow
Cash flow from continuing financing activities -3,975.70%-8.72M-151.27%-26.91M-99.94%34K-82.68%22K-26.75M-1,288.89%-214K-64.01%52.5M19.64%52.35M-93.90%127K0
Net issuance payments of debt ---8.75M---26.69M--1K---1K---26.69M--0--0--0--0----
Net common stock issuance ------0-99.46%281K-------------39.39%52.38M--52.38M--------
Proceeds from stock option exercised by employees 2,500.00%26K-63.23%57K230.00%33K-81.89%23K--0-94.44%1K-97.35%155K-41.18%10K-93.90%127K--0
Net other financing activities -----553.49%-281K-----------66K---215K96.95%-43K------------
Cash from discontinued financing activities
Financing cash flow -3,975.70%-8.72M-151.27%-26.91M-99.94%34K-82.68%22K---26.75M-1,288.89%-214K-64.01%52.5M19.64%52.35M-93.90%127K--0
Net cash flow
Beginning cash position -65.79%32.47M-57.16%94.91M-43.48%52.87M-61.04%56.23M-62.62%68.55M-57.16%94.91M6.62%221.56M-55.97%93.55M-40.96%144.33M-34.38%183.4M
Current changes in cash 53.22%-12.33M50.70%-62.44M-1,604.79%-20.41M93.40%-3.35M68.45%-12.32M30.94%-26.36M-1,020.79%-126.65M-85.09%1.36M-58.71%-50.78M-11.59%-39.06M
End cash Position -70.62%20.14M-65.79%32.47M-65.79%32.47M-43.48%52.87M-61.04%56.23M-62.62%68.55M-57.16%94.91M-57.16%94.91M-55.97%93.55M-40.96%144.33M
Free cash flow 69.37%-8.9M70.31%-38.34M58.24%-12.79M50.22%-10.58M136.06%14.09M23.91%-29.05M2.26%-129.13M11.62%-30.63M37.66%-21.25M-7.06%-39.06M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg